Cellular therapy in 2010: Focus on autoimmune and cardiac diseases

Israel Medical Association Journal

Volumn 12, Issue 2, 2010, Pages 110-115

  Perl, Leor ^a   Weissler, Adaya ^a   Mekori, Yoseph A ^a,b   Mor, Adam ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Cardiac diseases; Mesenchymal stromal cells; Stem cells; Transplantation

Indexed keywords

AUTOIMMUNE DISEASE; HEART DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYME CELL; NONHUMAN; PARACRINE SIGNALING; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; STROMA CELL;

AUTOIMMUNE DISEASES; HEART DISEASES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION;

EID: 77449126301     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Thomas ED, Lochte HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957; 157: 491-6.
2. Horwitz EM, Prather WR. Cytokines as the major mechanism of mesenchymal stem cell clinical activity: expanding the spectrum of cell therapy. IMAJ Isr Med Assoc J 2009; 11: 209-11.
3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
4. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 2004; 10: 3016-20.
5. van der Bogt KE, Schrepfer S, Yu J, et al. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009; 87: 642-52.
6. Tyndall A. Cellular therapy of autoimmune diseases. Rheumatologist 2008; 2: 1-29.
7. Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805-16.
8. Van Laar JM, Tyndall A. Adult stem cells in the treatment of autoimmune diseases. Rheumatology 2006; 45: 1187-93.
9. Jayne D, Passweg J, Marmont A, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13: 168-76.
10. Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295: 527-35.
11. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
12. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-76.
13. Psaltis PJ, Zannettino ACW, Worthley SG, Gronthos S. Concise review: Mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 2008; 26: 2201-10.
14. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103: 697-705.
15. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-8.
16. Yoon J, Min BG, Kim YH, et al. Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiol 2005; 60: 277-84.
17. Steingen C, Brenig F, Baumgartner L, et al. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol 2008; 44: 1072-84.
18. Langer HF, Stellos K, Steingen C, et al. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro: platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. J Mol Cell Cardiol 2009; 47: 315-25.
19. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703.
20. Dai Y, Xu M, Wang Y, et al. HIF-1α induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 2007; 42: 1036-44.
21. Yang ZJ, Ma DC, Xu SL, et al. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther 2006; 13: 1564-8.
22. Fazel S, Liwen C, Weisel R, et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. J Thorac Cardiovasc Surg 2005; 130: 1310-18.
23. Aupperle H, Garbade J, Schubert A, et al. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model. Vet Pathol 2007; 44: 494-503.
24. Angoulvant D, Fazel S, Weisel R, et al. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice. J Thorac Cardiovasc Surg 2009; 137: 471-80.
25. Atoui R, Shum-Tim D, Chiu RCJ. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells." Ann Thorac Surg 2008; 86: 327-34.
26. Augello A, Tasso R, Negrini SM, et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 2005; 35: 1482-90.
27. Schächinger V, Erbs S, Elsässer A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-21.
28. van Ramshorst J, Bax JJ, Beeres SL, et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009; 301: 1997-2004.
29. Hare JM. A double-blind, randomized placebo controlled clinical trial of allogeneic mesenchymal stem cells for the treatment of patients with acute myocardial infarction. ACC Annual Scientific Session 2007. http://www. cardiosource.com/RapidNewsSummaries/summary.asp?SumID=208
30. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 92-5.
31. Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362-9.
32. Chang MG, Tung L, Sekar RB, et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 2006; 113: 1832-41.
33. Fazel S, Angovulant D, Butany J, Weisel R, Li R. Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential. J Thorac Cardiovasc Surg 2008; 136: 1388-9.
34. Cao F, Van Der Bogt KE, Sadrzadeh A, et al. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev 2007; 16: 883-91.
35. Wakitani S, Nawata M, Tensho K, et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. Int J Biochem Cell Biol 2004; 36: 568-84.
36. Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogeneic bone marrow derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932-7.
37. Tzaribachev N, Vaegler M, Schaefer J, et al. Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis. IMAJ Isr Med Assoc J 2008; 10: 232-4.
38. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41.